S
Stockadora

Recent Material Events

Track the latest material events (8-K filings) with AI-powered analysis. Stay informed about major corporate developments, acquisitions, and changes.

📊 1175 Events
🤖 AI Analyzed
Recent
📄 Page 10 of 98
KROGER CO
8-K February 9, 2026

Key Highlights

  • Gregory S. Foran appointed CEO, bringing extensive experience from Walmart U.S. ...
  • Aims to accelerate Kroger's growth, enhance shareholder value, and strengthen ma...
  • Strategic focus expected on digital acceleration, supply chain optimization, and...
Read Analysis
🤖 AI Generated
XOMA Royalty Corp
8-K February 9, 2026

Key Highlights

  • XOMA Royalty Corp completed the acquisition of Generation Bio Co., a clinical-st...
  • This marks a major strategic shift for XOMA from a pure royalty model to direct ...
  • XOMA gains Generation Bio's proprietary non-viral gene therapy platform (ceDNA) ...
Read Analysis
🤖 AI Generated
APARTMENT INVESTMENT & MANAGEMENT CO
8-K February 9, 2026

Key Highlights

  • AIMCO is winding down operations through a 'Plan of Sale and Liquidation' to ret...
  • The company has declared an initial liquidating distribution of $1.45 per share.
  • Agreements are in place to sell 12 properties for approximately $680 million, wi...
Read Analysis
🤖 AI Generated
VOLITIONRX LTD
8-K February 9, 2026

Key Highlights

  • VolitionRx received a formal warning notice from the NYSE American for failing t...
  • The company's stock symbol will now include '.BC' (below compliance) to publicly...
  • VolitionRx must submit a plan to regain compliance by March 8, 2026.
Read Analysis
🤖 AI Generated
EDGEWELL PERSONAL CARE Co
8-K February 6, 2026

Key Highlights

  • Completed the transformative sale of its Feminine Care segment for approximately...
  • Optimizes the company's portfolio, enhances financial flexibility, and sharpens ...
  • Significant cash infusion strengthens the balance sheet and will primarily be us...
Read Analysis
🤖 AI Generated
ACCURAY INC
8-K February 6, 2026

Key Highlights

  • Accuray develops advanced radiation therapy systems for cancer treatment.
  • Company is actively evaluating options and intends to regain Nasdaq compliance.
  • Potential for strategic actions (new products, market expansion) to improve perf...
Read Analysis
🤖 AI Generated
ACTELIS NETWORKS INC
8-K February 6, 2026

Key Highlights

  • Actelis Networks has received a formal delisting notice from Nasdaq.
  • The company plans to formally request a hearing, which temporarily stays the del...
  • Shares will continue trading on Nasdaq while the appeal process unfolds.
Read Analysis
🤖 AI Generated
MOLINA HEALTHCARE, INC.
8-K February 6, 2026

Key Highlights

  • Sharpened Strategic Focus: Molina is doubling down on core government programs (...
  • Enhanced Financial Flexibility: Amended credit agreement provides crucial breath...
  • Streamlined Operations: Selling non-core assets like 'My Choice Wisconsin' to si...
Read Analysis
🤖 AI Generated
Lyra Therapeutics, Inc.
8-K February 6, 2026

Key Highlights

  • Nasdaq issued a delisting notice, classifying Lyra Therapeutics as a "public she...
  • The company halted development of its main drug candidate, LYR-210, due to sever...
  • Lyra Therapeutics laid off almost all its employees, including its CEO and CFO.
Read Analysis
🤖 AI Generated
YELP INC
8-K February 6, 2026

Key Highlights

  • Yelp Inc. acquired Hatchify Inc. for approximately $270 million in cash.
  • An additional $30 million is committed for retention packages for key Hatch empl...
  • The acquisition was partially financed by drawing on Yelp's existing credit faci...
Read Analysis
🤖 AI Generated
Lexaria Bioscience Corp.
8-K February 6, 2026

Key Highlights

  • Lexaria Bioscience is a biotech company focused on innovation.
  • Develops the DehydraTECH™ drug delivery platform.
  • Platform has specific applications for hypertension, diabetes, or cannabinoids.
Read Analysis
🤖 AI Generated
Vistagen Therapeutics, Inc.
8-K February 6, 2026

Key Highlights

  • Vistagen is a clinical-stage biopharmaceutical company focused on treatments for...
  • The company is actively exploring all options to regain Nasdaq compliance, inclu...
  • The Nasdaq non-compliance notice does not immediately affect Vistagen's current ...
Read Analysis
🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from material event filings with our AI-powered analysis. Track corporate developments, acquisitions, and strategic changes.

Back to Homepage